Literature DB >> 29862528

Estrogen-related receptor alpha triggers the proliferation and migration of human non-small cell lung cancer via interleukin-6.

Jing Zhang1, Xiangqian Guan2, Naixin Liang3, Shanqing Li3.   

Abstract

Human non-small cell lung cancer (NSCLC) is one of the leading causes of cancer deaths worldwide. Estrogenic signals have been suggested to be important for the growth and metastasis of NSCLC cells. Our present data showed that estrogen-related receptor alpha (ERRα), while not ERRβ or ERRγ, was significantly elevated in NSCLC cell lines as compared with that in normal bronchial epithelial cell line BEAS-2B. The expression of ERRα in clinical NSCLC tissues was significantly greater than that in their matched normal adjacent tissues. Over expression of ERRα can trigger the proliferation, migration, and invasion of NSCLC cells, while si-ERRα or ERRα inhibitor showed opposite effects. ERRα can increase the mRNA and protein expression of IL-6, while not IL-8, IL-10, IL-22, VEGF, TGF-β, or TNF-α, in NSCLC cells. Silence of IL-6 attenuated ERRα induced proliferation and cell invasion. Furthermore, our data revealed the inhibition of NF-κB, while not ERK1/2 or PI3K/Akt, abolished ERRα induced production of IL-6. This might be due to that overexpression of ERRα can increase the expression and nuclear translocation of p65 in NSCLC cells. Collectively, our data showed that activation of NF-κB/IL-6 is involved in ERRα induced migration and invasion of NSCLC cells. It suggested that ERRα might be a potential target for NSCLC treatment.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ERRα; IL-6; NF-κB; NSCLC

Mesh:

Substances:

Year:  2018        PMID: 29862528     DOI: 10.1002/cbf.3337

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  11 in total

1.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  ERRα expression in ovarian cancer and promotes ovarian cancer cells migration in vitro.

Authors:  Weiyi Huang; Lili Chen; Pengming Sun
Journal:  Arch Gynecol Obstet       Date:  2021-11-19       Impact factor: 2.344

3.  CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.

Authors:  Hang Li; Jun Che; Mian Jiang; Ming Cui; Guoxing Feng; Jiali Dong; Shuqin Zhang; Lu Lu; Weili Liu; Saijun Fan
Journal:  Cell Commun Signal       Date:  2020-09-17       Impact factor: 5.712

4.  17β-Estradiol promotes endometrial cancer proliferation and invasion through IL-6 pathway.

Authors:  Qi Che; Xirong Xiao; Jun Xu; Miao Liu; Yongning Lu; Suying Liu; Xi Dong
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

5.  ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes.

Authors:  Ping Li; Jian Wang; Desheng Wu; Xiaohu Ren; Wen Wu; Ran Zuo; Qingbo Zeng; Bingyu Wang; Xi He; Jianhui Yuan; Ni Xie
Journal:  Cancer Manag Res       Date:  2019-09-02       Impact factor: 3.989

6.  Effects of Bakuchiol on chondrocyte proliferation via the PI3K-Akt and ERK1/2 pathways mediated by the estrogen receptor for promotion of the regeneration of knee articular cartilage defects.

Authors:  Kang Xu; Yongqiang Sha; Sixiang Wang; Qingjia Chi; Yanju Liu; Chunli Wang; Li Yang
Journal:  Cell Prolif       Date:  2019-08-12       Impact factor: 6.831

Review 7.  The emerging role of estrogen related receptorα in complications of non-small cell lung cancers.

Authors:  Tapan K Mukherjee; Parth Malik; John R Hoidal
Journal:  Oncol Lett       Date:  2021-02-04       Impact factor: 2.967

Review 8.  Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective.

Authors:  Radhashree Maitra; Parth Malik; Tapan Kumar Mukherjee
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

9.  Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression.

Authors:  Zhenzhen Pan; Kai Wang; Xiniao Wang; Zhirong Jia; Yuqi Yang; Yalei Duan; Lianzhan Huang; Zhuo-Xun Wu; Jian-Ye Zhang; Xuansheng Ding
Journal:  Mol Cancer       Date:  2022-03-18       Impact factor: 27.401

10.  Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines.

Authors:  Márton Kalabay; Zsófia Szász; Orsolya Láng; Eszter Lajkó; Éva Pállinger; Cintia Duró; Tamás Jernei; Antal Csámpai; Angéla Takács; László Kőhidai
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.